Expression profiling of cancer-related galectins in acute myeloid leukemia
- 9 May 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (10) , 7929-7939
Abstract
Acute myeloid leukemia (AML) is the most common type of leukemia in adults with the lowest survival rate of all the leukemias. It is a heterogeneous disease in which a variety of cytogenetic and molecular alterations have been identified. Some galectins were previously reported to have important roles in cancer-like neoplastic transformation, tumor cell survival, angiogenesis, and tumor metastasis. Previous studies have showed that some galectin family members play a role in various types of leukemia. The present study aims at evaluating and clarifying the diagnostic and prognostic value of the expression of cancer-related galectins in relation to the clinicopathological characters of AML patients. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect expression profile of eight galectin family members (galectin-1, -2, -3, -4, -8, -9, -12, and -13) in 53 newly diagnosed de novo AML patients. The samples were collected from the inpatient clinic at National Cancer Institute (NCI), Cairo University (CU), diagnosed between July 2012 and May 2013. Our results show that patients with lower LGALS12 gene expression have a lower overall survival than those with higher expression (P value LGALS4 gene expression and patient age is found. Hence, the higher expression of LGALS4 gene is associated with younger age (adjusted P value <0.001). In conclusion, galectin-12 may be a potential prognostic marker for AML.Keywords
This publication has 43 references indexed in Scilit:
- PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 updateNucleic Acids Research, 2011
- Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Blood, 2011
- Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemiaProceedings of the National Academy of Sciences of the United States of America, 2011
- Synergistic Induction of Galectin-1 by CCAAT/Enhancer Binding Protein α and Hypoxia-inducible Factor 1α and Its Role in Differentiation of Acute Myeloid Leukemic CellsJournal of Biological Chemistry, 2011
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaBlood, 2011
- PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantificationNucleic Acids Research, 2009
- A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundanceBMC Genomics, 2008
- Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinomaEuropean Journal of Cancer, 2008
- [9] TM4 Microarray Software Suite2006
- Cell cycle arrest and induction of apoptosis by β galactoside binding protein (βGBP) in human mammary cancer cells. A potential new approach to cancer controlEuropean Journal of Cancer, 1999